MOLECULAR DEFECTS OF PROTEIN S AND FACTOR V (COFACTORS OF THE PROTEIN C ANTICOAGULANT PATHWAY) IN THE CONGENITAL THROMBOPHILIAS

Pubblicazioni Scientifiche

• 1996 THROMBOSIS AND HAEMOSTASIS

  Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma

• 1995 BRITISH JOURNAL OF HAEMATOLOGY

  RESISTANCE TO ACTIVATED PROTEIN-C IN HEALTHY WOMEN TAKING ORAL-CONTRACEPTIVES

• 2002 PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS

  Modulation of thrombophilia genes by environmental factors

• 1996 BRITISH JOURNAL OF HAEMATOLOGY

  Activated protein C resistance: A comparison between two clotting assays and their relationship to the presence of the factor V Leiden mutation

• 1997 THROMBOSIS AND HAEMOSTASIS

  New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V leiden mutation in Mediterranean populations and Indians

• 1995 THROMBOSIS AND HAEMOSTASIS

  PROTEIN-S MESSENGER-RNA IN PATIENTS WITH PROTEIN-S DEFICIENCY

• 1997 ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

  Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala(223)Val MTHFR) in patients with inherited thrombophilic coagulation defects

• 1996 THROMBOSIS AND HAEMOSTASIS

  A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects

• 1997 Blood

  A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype